McCabe, Christopher; Claxton, Karl; Culyer, Anthony J. - In: PharmacoEconomics 26 (2008) 9, pp. 733-744
The National Institute for Health and Clinical Excellence (NICE) has been using a cost-effectiveness threshold range between Lstg 20_000 and Lstg 30_000 for over 7 years. What the cost-effectiveness threshold represents, what the appropriate level is for NICE to use, and what the other factors...